The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IWWM-12 2024 | Using single-cell multi-omics to understand the progression from MGUS to WM
Carmen González Días-Cano, MSc, PhD(c), University of Navarra, Pamplona, Spain, discusses the value of single-cell multi-omics studies to characterize cell phenotypes. She mentions how differences between cell expression in Waldenström’s macroglobulinemia (WM) and monoclonal gammopathy of undetermined significance (MGUS) could be used to understand the progression from MGUS to WM. This interview took place at the 12th International Workshop on Waldenström’s Macroglobulinemia (IWWM-12) in Prague, Czech Republic.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
